Doxycycline vs Durvalumab

## Doxycycline vs Durvalumab: Overview

This comparison examines the pharmacological differences between **Doxycycline** and **Durvalumab**.

## Mechanism of Action

**Doxycycline**: Inhibits bacterial protein synthesis by binding 30S ribosomal subunit.

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Doxycycline — 18-22 hours; Durvalumab — 17 days.

## Chemical Properties

**Molecular Formula**: Doxycycline — C22H24N2O8; Durvalumab — N/A.

**Molecular Weight**: Doxycycline — 444.4350 g/mol; Durvalumab — N/A.

**Type**: Doxycycline — Small molecule; Durvalumab — Antibody.